TRIZLEX BIOPHARMA OÜ

Registered
11220756Private limited company (OÜ)Founded 2006

Key figures

1 288 202 €+30,5%
Revenue 2025
+37,2%
Average annual growth 2019–2025
0500 k1 m1,5 m2019202020212022202320242025

Ratios

2025

Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.

Summary: TRIZLEX BIOPHARMA OÜ

What kind of company is it?

TRIZLEX BIOPHARMA OÜ (registry code 11220756) is a private limited company (OÜ). The company was entered in the Commercial Register in 2006 and has been registered for 20 years. Registered location: Laagri alevik, Saue vald, Harju maakond. According to the latest annual report, the main activity is business and other management consultancy (EMTAK 70201). The company is registered for VAT (VAT number EE101030128).

How is the company doing financially?

Revenue in financial year 2025 was 1 288 202 €, up 30,5% on the previous year (987 018 €). From 2019 to 2025, revenue grew by an average of 37,2% per year. This is the company's highest revenue among the published years (2019–2025). Net profit for financial year 2025 was 900 245 € (69,9% of revenue). The company was profitable in 6 of the 7 published financial years. In financial year 2025 the company had 2 employees. Revenue per employee was 644 101 €. At the end of financial year 2025, total assets were 1 423 742 € and equity 1 373 696 € (96,5% of assets).

What do the latest quarters show?

According to the Tax and Customs Board, turnover in Q3 2026 was 676 895 €, up 105% on the same quarter a year earlier. The company had 2 employees in that quarter. Labour taxes paid in the quarter: 5488 €. Based on labour taxes, the estimated average gross salary in Q3 2026 was about 1770 € per month.

Who runs the company and who owns it?

The company has one management board member. The sole owner of the company is a private individual.

Where does the data come from and how fresh is it?

Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 29.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.

Quarterly figures
QuarterRevenueNumber of employeesLabour taxes
Q3 2026676 895 €25488 €
Q2 2026521 434 €25664 €
Q1 2026463 435 €25476 €
Q4 2025261 956 €25101 €
Q3 2025330 782 €25101 €
Q2 2025282 941 €25069 €
Q1 2025356 321 €24906 €

Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.

Dividends

calculated
2025

Distributed as dividends 418 807 € (47% of distributable profit).

History
2025418 807 €
20240 €
20230 €
20220 €
20210 €
20200 €
Summary of financial statements2021–2025
20212022202320242025
Sales revenue520 626285 240744 425987 0181 288 202
Net profit−16 08740 720323 849418 807900 245
Retained earnings117 301101 214144 490470 895470 895
Total assets135 770238 990606 395948 9581 423 742
Total liabilities32 00094 500135 50056 70050 046
Total equity103 770144 490470 895892 2581 373 696
Employees22222
Average gross salary (monthly)—34669816381611
Calculated dividend0000418 807

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Risks and obligations1 note6 clear
Register status
Registered
Business Register
Tax debt
None
Tax and Customs Board list of tax debtors
Enforcement and official notices
None
Official Announcements (Ametlikud Teadaanded)
Consumer disputes
None
Consumer Disputes Committee (TTJA)
Annual report filing
3/3 filed
Filed late: 2023
Business Register · 2023–2025
Commercial pledges
None
Business Register
Share pledges and disposal bans
None
Business Register

Data from public registers, not a credit rating.

Connections graph

Click a node to see its other connections.

100%TRIZLEX BIOPHARMA OÜ2Janno Kurg
CompanyPersonShareholderOther roleAdditional linkZoom: Ctrl/⌘ + scroll
Annual reportsPDF, XBRL

Loading list of reports…

Source: e-Business Register (RIK). Files open/download directly from the official register.

Related companies